FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
214518NDASIGA TECHNOLOGIES001TPOXXSOLUTION;INTRAVENOUS200MG/20ML (10MG/ML)TECOVIRIMAT2022-05-18PrescriptionYes
208627NDASIGA TECHNOLOGIES001TPOXXCAPSULE;ORAL200MGTECOVIRIMAT2018-07-13PrescriptionYes